Phase Forward Completes Acquisition – Analyst Blog
Source: http://www.zacks.com/stock/news/24269/Phase+Forward+Completes+Acquisition+-+Analyst+BlogPosted on Monday, August 31st, 2009 | In Stocks to Watch
Phase Forward (PFWD) recently announced that it completed its previously announced acquisition of the Interactive Voice and Web Response Services business of Covance Inc. (CVD) for $10 million in cash.
Headquartered in Princeton, New Jersey, Phase Forward is a leading provider of data management solutions for clinical trials and drug safety.
As part of the agreement, Phase Forward and Covance also entered into a multiyear marketing agreement. Management expects that this acquisition will strengthen its Interactive Response Technology solutions.
Earlier, the company reported second quarter results, which beat analysts’ expectations and trimmed its outlook for 2009. Management stated that it expects revenues between $214.5 and $217.5 million. On a non-GAAP basis, the company projects EPS between 47 cents and 50 cents, down from the average forecast of 54 cents and its prior guidance of 51 cents to 54 cents, primarily due to acquisition related costs of 4 cents to 5 cents.
Phase Forward is a leading vendor in the market for clinical trial management systems (CTMS) and electronic data capture (EDC) for clinical trials. The company provides software and services to pharmaceutical, biotechnology, medical device and other research-related companies and institutions. EDC utilization in the clinical trial process is currently under-penetrated and we believe that, at some point in the next decade, it will reach complete market saturation. Within that framework, Phase Forward is a best-in-class vendor of EDC and CTMS solutions to product developers.
We believe increasing adoption of EDC will benefit Phase Forward, and that the company’s product breadth could allow it to gain market share, allowing it to grow at above market rates, leading to positive revenue and earnings surprise and revisions.
Read the full analyst report on “PFWD”
Read the full analyst report on “CVD”
Zacks Investment Research
Last 5 posts by Zacks Market Commentaries
- CNP & FPL Ink Pipeline Deal - Analyst Blog - November 20th, 2009
- Buffett Borrows for Rail Acquisition - Analyst Blog - November 20th, 2009
- Stone Energy Outdoes Estimates - Analyst Blog - November 20th, 2009
- Smucker's Beats, Raises Guidance - Analyst Blog - November 20th, 2009
- GameStop Meets Expectations - Analyst Blog - November 20th, 2009
Biotechnology, cent;, clinical trial management systems, Covance Inc;, data management solutions, EDC, Interactive Voice, New Jersey, Phase Forward, Princeton, Stocks to Watch, USD, Web Response Services, Zacks Market Commentaries
 About Zacks Market Commentaries (http://www.zacks.com/)
Zacks Market Commentaries |
No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.